Clinical trial
The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary…
NCT00075998 · InterMune, Industry · Terminated
Key facts
| NCT number | NCT00075998 |
|---|---|
| Title | The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (The INSPIRE Trial) |
| Lead sponsor | InterMune, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Idiopathic Pulmonary Fibrosis, Lung Disease, Pulmonary Fibrosis |
| Intervention type | Drug |
| Interventions | Interferon gamma-1b ("Actimmune") |
| Enrollment | 826 |
| Start date | Dec 1, 2003 |
| Completion | May 1, 2007 |
| First posted | Jan 14, 2004 |
| Last update posted | Jul 2, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: